- Patent Title: Animal model for non alcoholic steato hepatitis and liver fibrosis
-
Application No.: US15635741Application Date: 2017-06-28
-
Publication No.: US10578611B2Publication Date: 2020-03-03
- Inventor: Robert Kleemann , Reinout Stoop , Johan Hendrikus Verheijen , Peter Ydo Wielinga , Teake Kooistra
- Applicant: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
- Applicant Address: NL 's-Gravenhage
- Assignee: Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek TNO
- Current Assignee: Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek TNO
- Current Assignee Address: NL 's-Gravenhage
- Agency: BakerHostetler
- Priority: NLPCT/NL2010/050757 20101115
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/68

Abstract:
The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (LDLr−/−) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a. feeding LDLr−/− mice, which have not been treated with streptozotocin, with a high energy diet; b. before, during and/or after this diet treating the mice with the preventive or therapeutic regimen; c. checking whether any change in the micro- or macrovascular system of the animal occurs. Specifically in such a method renal damage is assessed. Also use of said mice fed with a high energy diet for studying the diabetic micro- and macrovascular complications is part of the invention.
Public/Granted literature
- US20170363619A1 ANIMAL MODEL FOR DIABETIC COMPLICATIONS Public/Granted day:2017-12-21
Information query
IPC分类: